By ROBERT CYRAN
The $39 billion drug company only helped confirm some investor fears about its dealings involving Philidor Rx Services.
Published: October 27, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1LY4wrP
from WordPress http://ift.tt/1KBpfMx
via Hadi Aboukhater
No comments:
Post a Comment